New York Times editorial takes aim at drug industry give-aways

In an editorial this week, The New York Times calls for a national registry to track drug-company gifts to health care providers. “It’s no surprise that the pharmaceutical industry is appalled at proposals to set up a national registry of its gifts and payments to doctors,” The Times writes. “Too much information might lead patients to suspect that their doctors are choosing costly medicines out of gratitude to the manufacturers rather than for the best medical or economic interests of their patients.” Read the editorial

Comments are closed.